anti-GRP94-interferon

anti-GRP94-interferon is a **targeted antibody-cytokine fusion protein** described in patent literature as a non-naturally occurring molecule comprising an anti-GRP94 antibody or antigen-binding fragment linked to an interferon payload for cancer therapy. The construct is designed to bind **glucose-regulated protein 94** on GRP94-expressing tumor cells and deliver localized interferon signaling to the tumor microenvironment, with the intended effect of combining tumor targeting with the direct antiproliferative, pro-apoptotic, and immunostimulatory properties of interferon. Publicly accessible information appears limited to early intellectual-property disclosures rather than named clinical-stage development, and no clear proprietary non-code name, manufacturer, or marketed product could be confirmed from the available sources.

Other names

anti-GRP94-interferonanti-GRP-94-interferonanti-GRP 94-interferonGRP94 Ab-IFNGRP-94 Ab-IFNGRP 94 Ab-IFNanti-GRP94 interferon fusion moleculeanti-GRP-94 interferon fusion moleculeanti-GRP 94 interferon fusion moleculeGRP94 antibody-interferon fusion moleculeGRP-94 antibody-interferon fusion moleculeGRP 94 antibody-interferon fusion molecule